There are roughly 225,000 new cases of lung cancer every year in the United States. Early diagnosis and treatment play a large role in improving outcomes. A recently developed nasal swab test could ...

Researchers have found that testing for the presence of a single immune system molecule on nasal swabs can help detect stealthy viruses not identified in standard tests. As the COVID-19 pandemic ...

Researchers at the University of Pittsburgh have developed a new nasal swab test that identifies specific asthma subtypes in kids, which can lead to more accurate diagnoses and better treatment ...

A new paper describes a test that can differentiate between different types of asthma via a nasal swab. Researchers hope the test can eventually be used to help match patients with better treatments.

A new nasal swab test can accurately predict the severity of COVID-19 infections. It provides a more precise prediction than currently available of how serious the case is by focusing on ...

Researchers at the University of Pittsburgh have developed a nasal swab test for children and youth that helps clinicians diagnose specific asthma subtypes, or endotypes, using nasal epithelial gene ...

SalivaDirect in New Haven, Connecticut, was a finalist in The Spinoff Prize 2024. The company was spun off from Yale University in 2022. As the COVID-19 pandemic took hold in 2020, Anne Wyllie, a ...

Thea van de Mortel teaches into the infection prevention and control program at Griffith University. RATs should be kept at 2-30°C for them to work as intended. Storing at higher temperatures means ...

PITTSBURGH — A novel diagnostic test using just a nasal swab could transform how doctors diagnose and treat childhood asthma. Researchers at the University of Pittsburgh have developed this ...

WALTHAM, Mass.--(BUSINESS WIRE)--Rhinostics, Inc., an innovator in sample collection technologies, today announced that it has received Health Canada approval for sale of its RHINOstic™ Automated ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it has met its targeted enrollment for the NIGHTINGALE trial, which ...